1. Home
  2. DVAX vs POWW Comparison

DVAX vs POWW Comparison

Compare DVAX & POWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dynavax Technologies Corporation

DVAX

Dynavax Technologies Corporation

HOLD

Current Price

$10.90

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo AMMO Inc.

POWW

AMMO Inc.

HOLD

Current Price

$2.04

Market Cap

209.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
DVAX
POWW
Founded
1996
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ordnance And Accessories
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
209.6M
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
DVAX
POWW
Price
$10.90
$2.04
Analyst Decision
Buy
Strong Buy
Analyst Count
4
2
Target Price
$26.50
$2.38
AVG Volume (30 Days)
1.5M
367.5K
Earning Date
11-05-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$330,514,000.00
$46,632,638.00
Revenue This Year
$24.63
$9.85
Revenue Next Year
$15.85
$1.15
P/E Ratio
N/A
N/A
Revenue Growth
26.73
1343.57
52 Week Low
$9.20
$0.95
52 Week High
$14.63
$2.14

Technical Indicators

Market Signals
Indicator
DVAX
POWW
Relative Strength Index (RSI) 48.33 65.73
Support Level $10.76 $1.79
Resistance Level $10.97 $1.96
Average True Range (ATR) 0.24 0.07
MACD -0.06 0.01
Stochastic Oscillator 22.35 86.36

Price Performance

Historical Comparison
DVAX
POWW

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

About POWW AMMO Inc.

Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.

Share on Social Networks: